Regulatory frameworks governing the use of animals for scientific and research purposes, including project authorisation, welfare standards, and the implementation of the 3Rs (Replacement, Reduction, and Refinement).
Foresight tracks Animal Testing developments and surfaces the alerts most likely to matter before they turn into missed deadlines, recalls, or escalation work.
Not ready for a trial? Take the 3-minute readiness assessment
Current activity
In line with the prior 8-week baseline
3-month trend
Latest alerts below
Last updated
14 May 2026, 09:55
Source-backed regulatory and guidance signals tracked by Foresight, with the newest developments first.
South Korea Establishes Public–Private Task Force to Promote Animal-Free Chemical Hazard Assessment
In May 2026 South Korea created a 22-member public–private task force to accelerate animal-free methods for chemical hazard assessment and develop a national new approach methodologies (NAMs) strategy through 2035. This signals a strategic shift in Korean chemicals regulation toward validated non-animal data, so companies relying on traditional animal studies for regulatory hazard assessments should anticipate future legislative changes, new guidance, and capacity-building initiatives favouring NAMs.
South KoreaMinnesota House Introduces Bills on Tire Producer Stewardship and Severe Animal Testing Ban (HF 5129, HF 5131)
On 11 May 2026 the Minnesota House introduced bills to create a producer-funded tire recycling programme and to prohibit certain severe animal research procedures, both currently at first-reading stage. If enacted, these measures would tighten waste and research governance in Minnesota, requiring tire producers to finance end-of-life management and research organisations to redesign or relocate high-pain animal studies.
United StatesPortugal Adopts Decree-Law 96/2026 Transposing EU Rules on Animals Used for Scientific Purposes
Portugal has adopted Decree-Law 96/2026, published on 4 May 2026, amending its national framework and transposing Commission Delegated Directive (EU) 2024/1262 on the protection of animals used for scientific purposes. Research and testing organisations using animals in Portugal should anticipate updated legal expectations for animal welfare and scientific procedures and review how the revised framework could affect their approvals and internal controls.
Portugal
European UnionUK Updates Animal Research Licensing Guidance On Batch Quality Control Naming
The UK Home Office has updated its animal research licensing guidance under the Animals (Scientific Procedures) Act 1986 to add a section on naming products and substances in batch quality control and regulatory toxicology testing, with subsections reorganised for clarity. Organisations running animal-based regulatory studies should review project licence applications and templates to ensure products and substances are named in line with the referenced policy so that authorisations, audits, and compliance assessments are not delayed or challenged.
United KingdomUK Parliament Bill Would Ban Animals in Medical Research From 2035
A UK Private Member’s Bill would require regulations to ban the use of animals in medical research from 1 January 2035 and mandate non-animal methods for testing medicines and medical devices. If progressed, this would force a substantial redesign of UK preclinical testing and regulatory evidence requirements, accelerating investment in non-animal methodologies and potentially disrupting existing R&D pipelines ahead of the 2035 cut-off.
United KingdomEU Commission Confirms 2029 Ban on Animal-Tested Detergents and Plans Chemical Testing Roadmap
The European Commission has confirmed that the revised EU Detergents and Surfactants Regulation will, from 23 September 2029, ban placing on the market detergents and surfactants that were tested on animals to meet its requirements, and will publish a roadmap in Q2 2026 to phase out animal testing for chemical safety assessments. This strengthens long-term expectations that REACH, the Biocidal Products Regulation and related frameworks will progressively remove animal testing, requiring companies to plan earlier for alternative data and non-animal safety assessment methods.
European UnionUK Government Confirms Removal of Rabbit Pyrogen Test and Clarifies MHRA/Home Office Policy
In April 2026, UK parliamentary written answers confirmed that the rabbit pyrogen test was removed from the British Pharmacopoeia in 2025 and set out MHRA and Home Office positions that restrict its use in the UK to tightly controlled, exceptional cases for non-UK regulatory requirements. This reinforces a wider shift towards non-animal testing methods for medicines and devices, signalling that companies should plan for alternative pyrogen and preclinical testing strategies and expect closer scrutiny of any remaining rabbit-based protocols.
United KingdomECHA Consultation on REACH Testing Proposals for N-cyclohexylbenzothiazole-2-sulfenamide (CAS 95-33-0)
ECHA is consulting on REACH testing proposals for N-cyclohexylbenzothiazole-2-sulfenamide (EC 202-411-2, CAS 95-33-0), covering bioaccumulation, repeated-dose oral toxicity, in vivo genetic toxicity and reproductive toxicity, with comments due by 12 June 2026. The outcome will determine whether new vertebrate studies are required for this substance and structurally related analogues, influencing future hazard data, classification decisions and REACH compliance planning.
European UnionEU REACH: ECHA Testing Proposal Consultation for Triisobutyl Phosphate (Long-Term Fish Toxicity)
ECHA has added Triisobutyl phosphate (EC 204-798-3, CAS 126-71-6) to its REACH testing proposals list and is inviting third-party information on long-term toxicity to fish, with comments due by 12 June 2026. Manufacturers and downstream users relying on this substance should review existing aquatic toxicity data and consider submitting robust studies to influence the assessment and potentially avoid additional vertebrate testing and stricter classification outcomes.
European UnionEU REACH Testing Proposal for N‑tert‑Butylbenzothiazole‑2‑Sulphenamide (CAS 95‑31‑8)
In April 2026, ECHA opened a REACH testing proposal consultation on N-tert-butylbenzothiazole-2-sulphenamide (CAS 95-31-8), seeking vertebrate studies on reproductive and developmental toxicity with comments due by 12 June 2026. Companies manufacturing, importing or using this substance should quickly review existing data and coordinate any submissions, as the outcome may drive new testing requirements and future risk management decisions under REACH.
European UnionECHA Invites Information on REACH Testing Proposal for N,N-bis(2-hydroxyethyl)dodecanamide
European Chemicals Agency has opened a REACH testing proposal consultation for N,N-bis(2-hydroxyethyl)dodecanamide, covering repeated-dose oral and reproductive/developmental toxicity endpoints with comments due by 12 June 2026. Companies registering, manufacturing, or using this substance should review existing data and consider submitting robust studies to avoid unnecessary vertebrate testing and anticipate potential impacts on hazard classification and risk management.
European UnionECHA Opens REACH Testing Proposal Consultation for Lithium 12‑hydroxystearate (EC 231‑536‑5)
ECHA has opened a REACH testing‑proposal consultation on Lithium 12‑hydroxystearate, seeking third‑party data on several vertebrate toxicity endpoints with comments due by 12 June 2026. Registrants and other data holders should review existing studies and consider submitting relevant information, as this consultation will inform ECHA's evaluation of the testing proposal and the evidence base for this substance under EU REACH.
European UnionECHA Opens Consultation on REACH Testing Proposal for Dilithium Sebacate (EC 242-999-8)
ECHA has launched a REACH consultation on proposed vertebrate tests for Dilithium sebacate, with stakeholders invited to submit information by mid-June 2026. Companies manufacturing or using this substance should quickly review existing data, consider submissions to influence testing decisions, and anticipate how new hazard data could affect classification and downstream obligations.
European UnionECHA Opens Consultation on REACH Testing Proposal for Dichloro(methyl)(vinyl)silane
In April 2026, ECHA opened a REACH testing proposal consultation for dichloro(methyl)(vinyl)silane, seeking existing data on repeated-dose oral and developmental toxicity before approving new vertebrate studies. Registrants and downstream users should review toxicology portfolios now, consider submitting robust studies by 12 June 2026, and prepare for potential future hazard classification or risk-management actions based on ECHA’s assessment.
European UnionECHA Invites Information on REACH Testing Proposal for Bis(4-Methylbenzoyl)peroxide – Long-Term Toxicity to Fish
ECHA has opened a REACH consultation on a vertebrate long-term fish toxicity testing proposal for bis(4-methylbenzoyl)peroxide, with information due by 12 June 2026. Registrants and downstream users relying on this substance should assess existing aquatic toxicity data and consider submitting studies or arguments that could influence testing decisions and future regulatory requirements.
European UnionECHA Opens REACH Testing Proposal Consultation For Bis(4-isopropylphenyl)iodonium Tetraphenylborate
ECHA has opened a REACH testing proposal consultation on in vivo genetic toxicity (endpoint 7.6.2) for Bis(4-isopropylphenyl)iodonium tetraphenylborate (EC 679-512-7; CAS 1158840-74-4), with comments due by 12 June 2026. This may lead to additional vertebrate testing and inform future hazard classification, so registrants and affected supply chains should assess available data and decide whether to submit scientifically robust evidence.
European UnionECHA Opens REACH Testing Proposal Consultation for Amides C12-18 N-Hydroxyethyl
ECHA has opened a REACH testing proposal consultation on reproductive and developmental toxicity studies for Amides, C12-18(even-numbered) and C18(unsatd.), N-hydroxyethyl, with stakeholder submissions due by 12 June 2026. The outcome will determine whether new vertebrate tests go ahead and will shape future hazard assessment and regulatory requirements for this surfactant under REACH.
European UnionECHA Invites Information on REACH Testing Proposal for 1,2-Diaminotoluene, Ethoxylated and Propoxylated (EC 701-499-4)
In April 2026 ECHA opened a REACH testing‑proposal consultation on 1,2‑Diaminotoluene, ethoxylated and propoxylated (EC 701‑499‑4), seeking third‑party data on repeated‑dose and reproductive/developmental toxicity endpoints by 12 June 2026. This signals that additional hazard data may be required for this substance under REACH, so registrants and affected businesses should quickly assess any existing studies they hold and plan for potential impacts on classification and risk management.
European UnionUK Government Commissions Advice on Establishing Alternatives to Animals in Science Committee
In April 2026 the UK Government’s Office for Life Sciences formally commissioned the Animals in Science Committee to advise on creating a new expert committee focused on alternatives to the use of animals in science. This is an early governance step signalling future changes in how non-animal methods are coordinated and integrated into the UK research and regulatory system, so R&D and regulatory teams should monitor its outputs for potential impacts on testing strategies and investment priorities.
United KingdomUS FDA Reports Year One Progress on Reducing Animal Testing in Drug Development
In April 2026 the US FDA released a Year One progress report on its roadmap for reducing animal testing in nonclinical drug studies, highlighting milestones such as NAMs validation guidance, reduced primate studies, an AI-based tool qualification and a searchable NAMs acceptability database. This signals a structural shift towards human-relevant testing methods, so drug developers should plan for NAMs to become the expected default in nonclinical safety strategies and align pipelines, data packages and internal capabilities accordingly.
United StatesThese are just a few of the most recent Animal Testing alerts. Foresight tracks every jurisdiction, every day — and surfaces only what affects your portfolio, with full citations and evidence.
Start free trialTopic context
Definition
Regulatory frameworks governing the use of animals for scientific and research purposes, including project authorisation, welfare standards, and the implementation of the 3Rs (Replacement, Reduction, and Refinement).
Industry relevance
Animal Testing developments can change product scope, supplier expectations, market access, reporting duties, and risk ownership. Foresight tracks the signals early so teams can respond before obligations become urgent.
Foresight tracking
Foresight monitors official sources, extracts structured regulatory intelligence, and maps alerts to a customer's products, substances, markets, and priorities so teams see the relevant signal with source evidence for review.
Everything you need to know about Foresight's regulatory intelligence platform
Still have questions? Get in touch with our team
Subscribe to Foresight Weekly for expert-picked regulatory developments across chemicals, sustainability, product safety, ESG, and HSE.
Free forever. Unsubscribe anytime.
Read by professionals at
